Cargando…

Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data

BACKGROUND: One of the malignant tumors is Breast Cancer (BC) that starts in the cells of breast. There is many models for survival analysis of patients such as Cox PH model, Parametric models etc. But some disease are that all of patients will not experience main event then usual survival model is...

Descripción completa

Detalles Bibliográficos
Autores principales: Baghestani, Ahmad Reza, Shahmirzalou, Parviz, Sayad, Soheila, Akbari, Mohammad Esmaeil, Zayeri, Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103589/
https://www.ncbi.nlm.nih.gov/pubmed/29936785
http://dx.doi.org/10.22034/APJCP.2018.19.6.1601
_version_ 1783349367225188352
author Baghestani, Ahmad Reza
Shahmirzalou, Parviz
Sayad, Soheila
Akbari, Mohammad Esmaeil
Zayeri, Farid
author_facet Baghestani, Ahmad Reza
Shahmirzalou, Parviz
Sayad, Soheila
Akbari, Mohammad Esmaeil
Zayeri, Farid
author_sort Baghestani, Ahmad Reza
collection PubMed
description BACKGROUND: One of the malignant tumors is Breast Cancer (BC) that starts in the cells of breast. There is many models for survival analysis of patients such as Cox PH model, Parametric models etc. But some disease are that all of patients will not experience main event then usual survival model is inappropriate. In addition, In the presence of cured patients, if researcher can specify distribution of survival time, usually cure rate models are preferable to parametric models. Distribution of Survival time can be Weibull, Log normal, Logistic, Gamma and so. Comparison of Weibull, Log normal and Logistic distribution for finding the best distribution of survival time is purpose of this study. MATERIAL AND METHODS: Among 787 patients with BC by Cancer Research Center recognized and followed from 1985 until 2013. Variables stage of cancer, age at diagnosis, tumor size and Number of Removed Positive Lymph Nodes (NRPLN) for fitting Cure rate model were selected. The best model selected with DIC criteria. All analysis were performed using SAS 9.2. RESULTS: Mean (SD) of age was 48.47 (11.49) years and Mean of survival time and Maximum follow up time was 326 and 55.12 months respectively. During following patients, 145 (18.4%) patients died from BC and others survived (censored). Also, 1-year, 5-year and 10-year survival rate was 94, 77 and 56 percent respectively. Log normal model with smaller DIC were selected and fitted. All of mentioned variables in the model were significant on cure rate. CONCLUSION: This study indicated that survival time of BC followed from Log normal distribution in the best way.
format Online
Article
Text
id pubmed-6103589
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-61035892018-08-28 Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data Baghestani, Ahmad Reza Shahmirzalou, Parviz Sayad, Soheila Akbari, Mohammad Esmaeil Zayeri, Farid Asian Pac J Cancer Prev Research Article BACKGROUND: One of the malignant tumors is Breast Cancer (BC) that starts in the cells of breast. There is many models for survival analysis of patients such as Cox PH model, Parametric models etc. But some disease are that all of patients will not experience main event then usual survival model is inappropriate. In addition, In the presence of cured patients, if researcher can specify distribution of survival time, usually cure rate models are preferable to parametric models. Distribution of Survival time can be Weibull, Log normal, Logistic, Gamma and so. Comparison of Weibull, Log normal and Logistic distribution for finding the best distribution of survival time is purpose of this study. MATERIAL AND METHODS: Among 787 patients with BC by Cancer Research Center recognized and followed from 1985 until 2013. Variables stage of cancer, age at diagnosis, tumor size and Number of Removed Positive Lymph Nodes (NRPLN) for fitting Cure rate model were selected. The best model selected with DIC criteria. All analysis were performed using SAS 9.2. RESULTS: Mean (SD) of age was 48.47 (11.49) years and Mean of survival time and Maximum follow up time was 326 and 55.12 months respectively. During following patients, 145 (18.4%) patients died from BC and others survived (censored). Also, 1-year, 5-year and 10-year survival rate was 94, 77 and 56 percent respectively. Log normal model with smaller DIC were selected and fitted. All of mentioned variables in the model were significant on cure rate. CONCLUSION: This study indicated that survival time of BC followed from Log normal distribution in the best way. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6103589/ /pubmed/29936785 http://dx.doi.org/10.22034/APJCP.2018.19.6.1601 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Baghestani, Ahmad Reza
Shahmirzalou, Parviz
Sayad, Soheila
Akbari, Mohammad Esmaeil
Zayeri, Farid
Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data
title Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data
title_full Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data
title_fullStr Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data
title_full_unstemmed Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data
title_short Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data
title_sort comparison cure rate models by dic criteria in breast cancer data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103589/
https://www.ncbi.nlm.nih.gov/pubmed/29936785
http://dx.doi.org/10.22034/APJCP.2018.19.6.1601
work_keys_str_mv AT baghestaniahmadreza comparisoncureratemodelsbydiccriteriainbreastcancerdata
AT shahmirzalouparviz comparisoncureratemodelsbydiccriteriainbreastcancerdata
AT sayadsoheila comparisoncureratemodelsbydiccriteriainbreastcancerdata
AT akbarimohammadesmaeil comparisoncureratemodelsbydiccriteriainbreastcancerdata
AT zayerifarid comparisoncureratemodelsbydiccriteriainbreastcancerdata